Nuclear Medicine Equipment Market to Reach $10 Billion by 2035 as Imaging Demand Grows

The global nuclear medicine equipment market is predicted to reach approximately USD 10.00 billion by 2035, up from USD 7.34 billion in 2025, expanding at a CAGR of 3.14% from 2026 to 2035. This market is growing due to the rising prevalence of cancer and cardiovascular diseases, along with increasing demand for advanced diagnostic imaging technologies.

The global PET scanners market is expected to reach US$ 3.80 billion by 2033, up from US$ 2.73 billion in 2024, expanding at a compound annual growth rate of 3.73% from 2025 to 2033. PET scanners are sophisticated medical imaging devices designed to visualize metabolic processes in the body by using radiotracers that emit positrons, generating high-resolution images that show how tissues and organs function in real time.

North America dominated the nuclear medicine equipment market with a 43% share in 2025, while Asia Pacific is expected to grow at a CAGR of 5.0% between 2026 and 2035. By product, the SPECT systems segment held the biggest market share of 58% in 2025, while the hybrid PET/SPECT/CT segment is expected to expand at a solid CAGR of 3.9% between 2026 and 2035.

Hybrid imaging systems such as PET/CT and SPECT/CT are increasingly being used to provide more accurate, detailed, and comprehensive diagnostic results by combining functional and anatomical imaging in a single scan. These combined systems are now widely used for tumor staging, treatment planning, and therapy monitoring.

By application, the oncology segment contributed to the highest market share of 50% in 2025 in the nuclear medicine equipment market. The neurology segment is expected to grow at a robust CAGR of 4.0% between 2026 and 2035. PET scans are particularly valuable in neurology because they can detect abnormal brain metabolism and identify biomarkers such as amyloid plaques associated with Alzheimer's disease.

By end user, the hospitals segment held a major market share of 60% in 2025, while the imaging centers segment is expected to expand at the fastest CAGR of 4.1% from 2026 to 2035. By detector technology, the NaI segment held the biggest market share of 70% in 2025, while the solid state/CZT segment is expected to expand at the fastest CAGR of 4.3% between 2026 and 2035.

Artificial intelligence is transforming the nuclear medicine equipment market by improving image reconstruction, lesion detection, and diagnostic accuracy. AI-powered algorithms analyze complex imaging data from PET and SPECT systems more rapidly and accurately. AI also facilitates workflow automation, predictive analytics, and dose optimization, which allows for more individualized treatment planning and boosts overall productivity in nuclear medicine departments.

Technologies such as time-of-flight imaging and digital PET detectors have greatly enhanced image resolution and sensitivity while reducing scan times and radiation exposure. Continuous improvements in image resolution, faster scanning technologies, and enhanced software capabilities are improving diagnostic accuracy and patient outcomes.

The development of new radiotracers and radiopharmaceuticals is expanding the clinical applications of nuclear medicine in oncology, cardiology, and neurology. Rising public and private investments in advanced diagnostic infrastructure are supporting the adoption of modern nuclear medicine equipment across healthcare facilities. Expanding healthcare access and improving diagnostic capabilities in developing regions are creating new growth opportunities for nuclear medicine equipment manufacturers.